Detalhe da pesquisa
1.
miR-205 in Breast Cancer: State of the Art.
Int J Mol Sci
; 22(1)2020 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375067
2.
MicroRNA and Oxidative Stress Interplay in the Context of Breast Cancer Pathogenesis.
Int J Mol Sci
; 20(20)2019 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31627322
3.
The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective.
Cancers (Basel)
; 14(21)2022 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358746
4.
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study.
Cancer Med
; 11(2): 332-339, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921525
5.
Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay.
Cancers (Basel)
; 13(15)2021 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359591
6.
Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended.
Cancers (Basel)
; 13(16)2021 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439180
7.
miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts.
Cells
; 9(9)2020 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32972039
8.
MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer.
Cancers (Basel)
; 12(8)2020 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32806777
9.
Mexican Ganoderma Lucidum Extracts Decrease Lipogenesis Modulating Transcriptional Metabolic Networks and Gut Microbiota in C57BL/6 Mice Fed with a High-Cholesterol Diet.
Nutrients
; 13(1)2020 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33374283
10.
MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers.
Front Oncol
; 8: 352, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30234015
11.
Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer.
Sci Rep
; 8(1): 12252, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115973